3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
13
Neoplasms
8
Breast Neoplasms
4
Hypogonadism
3
Testicular Neoplasms
2
Polycystic Ovary Syndrome
2
Fatigue
2
Dyspareunia
2
Arthralgia
2
Vaginitis
1
Sleep Apnea, Obstructive
1
Sleep Apnea Syndromes
1
Sexuality
1
Sexual Dysfunction, Physiological
1
Osteoporosis
1
Obesity
1
Neoplasm Metastasis
1
Muscle Weakness
1
Multiple Endocrine Neoplasia Type 1
1
Motor Activity
1
Metabolic Syndrome
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Infertility
1
Hot Flashes
1
Eunuchism
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Neoplasms, Male
1
Interventions
Metformin
7
Magnetic Resonance Spectroscopy
2
Inositol
2
Exercise
2
Ethinyl Estradiol
2
maltodextrin
1
drospirenone and ethinyl estradiol combination
1
drospirenone
1
Walking
1
Triptorelin Pamoate
1
Testosterone
1
Sugars
1
Spironolactone
1
Pyruvic Acid
1
Preoperative Exercise
1
Pioglitazone
1
Phlebotomy
1
Pancreaticoduodenectomy
1
Orchiectomy
1
Leuprolide
1
Hepatectomy
1
Flutamide
1
Etanercept
1
Estrogens
1
Diet, Reducing
1
Diet, Mediterranean
1
Diet, Fat-Restricted
1
Diet Therapy
1
Diet
1
Diathermy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Metabolic Syndrome
×
Testosterone
×
Clear all
NCT02991209
2020-03-06
Einstein
Rigshospitalet, Denmark
Phase 2/3
Completed
69 enrolled